Skip to main content
. 2022 Apr 7;13:1891. doi: 10.1038/s41467-022-29413-2

Table 1.

SARS-CoV-2 inhibition data for GC376 analogs.

Entry SARS-CoV-2 3CLpro IC50 (nM) SARS-CoV-2 3CLpro kinact/KI (min−1 µM−1) SARS-CoV-2 Vero E6 EC50 (µM) SARS-CoV-2 Huh-7ACE2 EC50 (nM) SARS-CoV-2 Caco-2 EC90 (nM)
GC376 35 1.3 9 51
EB46 23 3.3 2 14 53
EB48 200 2.1 16
EB54 29 5.3 2 5 190
EB55 72 1.3 3 11
EB56 50 1.1 4 28
SL-4-241 75 1.4 17
NK01-14 22 4.3 26
NK01-48 92 0.3 15
NK01-57 13 NA 92
NK01-63 16 4.4 6 81
NK01-69 24 4.2 35